2021/2800(DEA)
Evaluation of notifications by national competent authorities to the Commission and inclusion of cicatrizants with ATC code D03AX and pharmaceutical form fly larvae in the list of medicinal products that shall not bear the safety features
Basic information
2021/2800(DEA)
DEA - Delegated acts procedure
Supplementing 1999/0134(COD)
Subject
4.20.01 Medicine, diseases
4.20.04 Pharmaceutical products and industry
Status
Procedure completed - delegated act enters into force
Key players
-
European Parliament
Committee responsible Rapporteur Appointed
Key events
| Date | Event | Reference | Summary |
|---|---|---|---|
| 07/07/2021 | Non-legislative basic document published | C(2021)04934 | |
| 07/07/2021 | Initial period for examining delegated act 2.0 month(s) | ||
| 08/07/2021 | Committee referral announced in Parliament | ||
| 15/09/2021 | Delegated act not objected by Parliament |
Technical information
| Procedure | Information |
|---|---|
| Procedure reference | 2021/2800(DEA) |
| Procedure type | DEA - Delegated acts procedure |
| Nature of procedure | Examination of delegated act |
| Supplementing 1999/0134(COD) | |
| Stage reached in procedure | Procedure completed - delegated act enters into force |
| Committee dossier |
ENVI/9/06772
|
Documentation gateway
-
Document type Reference Date Summary Non-legislative basic document C(2021)04934 07/07/2021